Back to Pharma and BioTech Daily

Podcast Episode

FDA Extends Capricor Review: $2.25B McKesson Deal | Pharma and Biotech Daily

Pharma and BioTech Daily·Pharma and BioTech News·5 September 2026·5 min

FDA Extends Capricor Review: $2.25B McKesson Deal | Pharma and Biotech Daily cover art

Home Search Profile